ArticlebioRxiv : the preprint server for biology2026
Benchmarking foundation models for splice site and exon annotation.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Recent foundation and deep learning models have brought a generational leap in improving the quality of genome annotation, particularly in identifying genes and their structural elements, including exons and splice sites. However, they are trained on reduced datasets that may not capture biological complexity, such as differences between coding versus non-coding, terminal versus internal, constitutive versus alternatively spliced, and transposable element (TE)-derived exons. We evaluate several foundation models for gene and splice site annotation, including the transformer-based SegmentNT, Enformer and Borzoi, coupled with a segmentation head for per-base resolution, and the CNN-based SpliceAI and AlphaGenome, along with a newly developed fine-tuned model, STEP2h, on different classes of gene elements as described above. We found that the performance of all methods is highest for the class of exons found in their training data class and decreases drastically for classes of exons poorly represented. In particular, performance is highest for protein-coding genes, coding exons, and constitutive exons, and decreases drastically by up to 2-4 fold for non-coding internal exons, terminal exons, and exons that undergo alternative splicing. Similarly, performance is impaired on LINE-1 and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.